|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
1986-4-17
|
|
pubmed:abstractText |
Eighty patients with duodenal ulcer were randomly allocated to treatment with tripotassium dicitrato bismuthate (TDB) tablets or cimetidine. Ulcers healed in 78% of patients treated with TDB and in 74% treated with cimetidine, supporting previous observations that the efficacy of these two agents is similar. Duodenal ulcer recurred in 43% of patients in the 12 months after treatment with TDB and in 78% of patients treated with cimetidine, with a significantly greater incidence of recurrence 6-12 months after cimetidine treatment. Tripotassium dicitrato bismuthate tablets may be preferable to cimetidine in the initial management of duodenal ulcer, because they offer a smaller likelihood of recurrence in the 12 months after successful treatment.
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/3512382,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3512382-295504,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3512382-6109102,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3512382-6145023,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3512382-6147588,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3512382-6147723,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3512382-6357964,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3512382-6994084,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3512382-7000628,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3512382-7034155,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3512382-7047268
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0017-5749
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
27
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
106-10
|
|
pubmed:dateRevised |
2009-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:3512382-Adult,
pubmed-meshheading:3512382-Aged,
pubmed-meshheading:3512382-Anti-Ulcer Agents,
pubmed-meshheading:3512382-Bismuth,
pubmed-meshheading:3512382-Cimetidine,
pubmed-meshheading:3512382-Clinical Trials as Topic,
pubmed-meshheading:3512382-Duodenal Ulcer,
pubmed-meshheading:3512382-Female,
pubmed-meshheading:3512382-Humans,
pubmed-meshheading:3512382-Male,
pubmed-meshheading:3512382-Middle Aged,
pubmed-meshheading:3512382-Organometallic Compounds,
pubmed-meshheading:3512382-Recurrence
|
|
pubmed:year |
1986
|
|
pubmed:articleTitle |
Healing and recurrence of duodenal ulcer after treatment with tripotassium dicitrato bismuthate (TDB) tablets or cimetidine.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|
